Thai PBS Thai PBS
Thai FDA discourages use of rapid test kits to assess immunity after COVID vaccination

Thai FDA discourages use of rapid test kits to assess immunity after COVID vaccination

13 Sept 13:15 Key points summarised by AI
  • Thailand's FDA advises against using commercial rapid antibody test kits to assess post-COVID vaccination immunity, citing their unreliability and potential for false results.
  • FDA Deputy Secretary-General Dr. Surachoke Tangvivat clarified that these kits might not detect the specific antibodies triggered by vaccines, leading to inaccurate readings.
  • Credible immunity assessment requires medical experts and laboratory analysis using complex equipment, not rapid tests, to ensure accurate and reliable results.
  • Officials refuted social media reports questioning Sinovac vaccine efficacy, providing evidence from proper testing and research demonstrating its effectiveness in triggering antibody production.
Read full article
Thai PBS World 1/1
Skip > Skip >